Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB.

@article{Mikati2020AntimicrobialPA,
  title={Antimicrobial Prodrug Activation by the Staphylococcal Glyoxalase GloB.},
  author={Marwa O. Mikati and Justin J. Miller and Damon M. Osbourn and Yasaman Barekatain and Naomi Ghebremichael and Isha Shah and Carey-Ann D. Burnham and Kenneth M. Heidel and Victoria C. Yan and Florian L. Muller and Cynthia S. Dowd and Rachel L. Edwards and Audrey R. Odom John},
  journal={ACS infectious diseases},
  year={2020}
}
With the rising prevalence of multidrug resistance, there is an urgent need to develop novel antibiotics. Many putative antibiotics demonstrate promising in vitro potency but fail in vivo due to poor drug-like qualities (e.g., serum half-life, oral absorption, solubility, and toxicity). These drug-like properties can be modified through the addition of chemical protecting groups, creating "prodrugs" that are activated prior to target inhibition. Lipophilic prodrugging techniques, including the… Expand
3 Citations
Structure-guided microbial targeting of antistaphylococcal prodrugs
TLDR
The identifies the bacterial esterases, GloB and FrmB, that are required for carboxy ester prodrug activation in Staphylococcus aureus and establishes the substrate specificities of human and mouse sera, which lay the groundwork for structure-guided design of anti-staphyloccal promoieties and expand the range of molecules to target staphylOCcal pathogens. Expand
Structure-guided microbial targeting of antistaphylococcal prodrugs
TLDR
This work identifies the bacterial esterases, GloB and FrmB, that activate carboxy ester prodrugs in Staphylococcus aureus and establishes the substrate specificities of human and mouse sera, ultimately identifying several promoieties likely to be serum esterase-resistant and microbially labile. Expand
Could β-Lactam Antibiotics Block Humoral Immunity?
TLDR
The literature data supporting the hypothesis that β-lactam antibiotics can block the SNM1C/Artemis protein in humans inducing transient immunodeficiency is reviewed, based on in silico, in vitro and in vivo evidences. Expand

References

SHOWING 1-10 OF 61 REFERENCES
Potent, specific MEPicides for treatment of zoonotic staphylococci
TLDR
It is demonstrated that fosmidomycin (FSM) inhibits the first step of the isoprenoid biosynthetic pathway catalyzed by deoxyxylulose phosphate reductoisomerase (DXR) in staphylococci, and that DXR represents a promising, druggable target for future development. Expand
Lipophilic Prodrugs of FR900098 Are Antimicrobial against Francisella novicida In Vivo and In Vitro and Show GlpT Independent Efficacy
TLDR
Several FR900098 prodrugs are synthesized that have lipophilic groups to facilitate their passage through the bacterial cell wall and bypass the requirement for the GlpT transporter, and one compound, that is termed “compound 1,” has the potential to be a broad-spectrum antibiotic and should be effective against most MEP-dependent organisms. Expand
Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
TLDR
The results show that this strategy can be an effective way for improving whole cell activity of NMP inhibitors, and several of these compounds show improved antibacterial activity against a panel of organisms relative to the parent compound, including activity against Mycobacterium tuberculosis. Expand
Resistance of Francisella Novicida to Fosmidomycin Associated with Mutations in the Glycerol-3-Phosphate Transporter
TLDR
It is concluded that one mechanism of resistance of F. novicida to Fos is caused by mutations in GlpT, the first description of spontaneous mutations in Francisella leading to FOSR. Expand
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
TLDR
A diarylquinoline, R207910, is identified that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro and mutants selected in vitro suggest that the drug targets the proton pump of adenosine triphosphate (ATP) synthase. Expand
MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis
TLDR
RCB-185 is described, a lipophilic prodrug with nanomolar activity against asexual parasites that effectively treated sexually-committed parasites and was both safe and efficacious in malaria-infected mice. Expand
Manuka honey and methylglyoxal increase the sensitivity of Staphylococcus aureus to linezolid
TLDR
Manuka honey, as well as MGO in isolation, increases the sensitivity of S. aureus to linezolid in both agar diffusion and broth microdilution assays, mediated in part by increased intracellular accumulation of lineZolid in the presence of MGO. Expand
Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
TLDR
Two series of analogs are uncovered that potently inhibit Dxr homologues from Mtb and Yp, serving as leads for future analog development of MEPicides. Expand
The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism Matters.
TLDR
This review surveys the mechanisms of MBL inhibitors and describes methods that determine the mechanism of inhibition to guide development of future therapeutics. Expand
The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
TLDR
This work synthesized ethyl and pivaloyl esters of these compounds to increase lipophilicity and improve inhibition of Mtb growth, and shows that propyl or propenyl linker chains are optimal. Expand
...
1
2
3
4
5
...